A larger 228-adult double-blind, randomized, placebo-controlled, dose-ranging trial in functional constipation (Rome III criteria) tested 1 10 and 1 10 CFU per day for 28 days against placebo
Courtesy Dr Bob Goode, Tufts University
A Randomized Controlled Trial of The GLP-1 Receptor Agonist Dulaglutide in Primary Polydipsia
Research Use Disclaimer The compounds distributed by USA PEPTIDE SCIENCES , including Retatrutide 6mg, are designated strictly for laboratory research purposes only
doi: 10.1186/s43556-023-00165-9 Summary Keywords reactive oxygen species, oxidative stress, prostatitis, prostate cancer, tumor microenvironment, inflammation-cancer Citation Tang K, Jiang Z, Luo W, Li J, Liang D, Liu L and Long Z (2025) The role of reactive oxygen species in the transformation from prostatitis to prostate cancer: a review